These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 556872)

  • 1. [A comparison of serum phosphohexose isomerase and sialyl transferase activities in patients with malignant disease].
    Bayer PM; Ganzinger U; Burger EC; Gergely T; Gabl F; Moser K
    Wien Klin Wochenschr; 1977 Jan; 89(1):16-7. PubMed ID: 556872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical application of serum sialyl transferase determination as criterion of malignant transformation of cell surface structure (author's transl)].
    Ganzinger U
    Wien Klin Wochenschr; 1977 Sep; 89(17):594-7. PubMed ID: 906522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum lactate dehydrogenase, phosphohexose isomerase, aldolase and hexokinase in prostatic carcinoma.
    Yeshowardhana
    Indian J Physiol Pharmacol; 1985; 29(1):33-8. PubMed ID: 2414222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical studies in breast carcinoma. 1. Serum phosphohexose isomerase, lactate dehydrogenase and its isoenzyme changes.
    Saravanan CS; Balasubramanian MK; Gopalakrishnan V; Govindarajulu P; Nanjunda Rao R
    Indian J Cancer; 1977 Mar; 14(1):38-41. PubMed ID: 885568
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase.
    Gault MH; Cohen MW; Kahana LM; Leelin FT; Meakins JF; Aronovitch M
    Can Med Assoc J; 1967 Jan; 96(2):87-94. PubMed ID: 6017171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic changes in breast carcinoma. II. Phosphohexose isomerase and lactic dehydrogenase levels in serum.
    Maity CR; Burma DP
    Indian J Cancer; 1973 Sep; 10(3):356-60. PubMed ID: 4785884
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic and prognostic significance of serum phosphohexose isomerase, aldolase and hexokinase in carcinoma cervix.
    Yeshowardhana ; Sangita
    Indian J Physiol Pharmacol; 1986; 30(2):177-81. PubMed ID: 3818045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialyl transferase activity: a serum enzyme marker in the follow-up of cancer patients.
    Ganzinger U; Moser K
    Recent Results Cancer Res; 1979; 67():50-5. PubMed ID: 451323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The determination of phosphohexose isomerase in patients with cancer of breast and uterus. A comparison with other tests (author's transl)].
    Telesforo P; Rosenberg R
    Quad Sclavo Diagn; 1978 Sep; 15(3):365-72. PubMed ID: 37546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme tests in cancer.
    Schwartz MK
    Clin Lab Med; 1982 Sep; 2(3):479-91. PubMed ID: 6128099
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of serum phosphohexose isomerase, hexokinase and aldolase in carcinoma ovary.
    Yeshowardhana ; Singh VS
    Indian J Physiol Pharmacol; 1985; 29(1):51-4. PubMed ID: 4055017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of 4 biological markers: lactate dehydrogenase, phosphoglucoisomerase, carcinoembryonic antigen and gammaglutamyl transpeptidase, systematically determined in patients in a hematology-oncology department].
    Taillan B; Barthelemy G; Routy JP; Pedinielli FJ; Zarrouk F; Chardon H; Blanc AP
    Pathol Biol (Paris); 1987 Apr; 35(4):375-80. PubMed ID: 2884616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation and use of a carrier-bound acceptor for the determination of sialyl transferase activity in serum.
    Ganzinger U; Unger FM
    J Clin Chem Clin Biochem; 1985 Oct; 23(10):691-5. PubMed ID: 2415667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lactic dehydrogenase and other enzymes in malignant disease. Comparison with an immunodiagnostic test for cancer.
    Ratliff CR; Culp TW; Hall FF
    Am J Gastroenterol; 1971 Sep; 56(3):199-208. PubMed ID: 5001083
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of phosphohexose isomerase (PHI) determination in myocardial infarct].
    Guidollet J; Devic J; Ripoll JP
    Arch Mal Coeur Vaiss; 1975 Oct; 68(10):1103-8. PubMed ID: 816276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The activity of isocitra dehydrogenase and of phosphohexose isomerase in the serum of patientwith malignant tumors of the mouth cavity].
    Casella M
    Arch Stomatol (Napoli); 1968; 9(4):359-63. PubMed ID: 5267533
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of the determination of serum phosphohexose isomerase in malignant neoplasms].
    Bruno GF; Failla G; Foti E; Marchese V
    Minerva Med; 1978 Mar; 69(12):749-56. PubMed ID: 643216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme spectrum of the blood in malignant breast neoplasms].
    Lugovoĭ VI; Kravchenko LP; Kutsyĭ AS
    Vopr Onkol; 1972; 18(5):20-3. PubMed ID: 5043964
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic significance of serum phosphohexose isomerase in metastatic breast cancer].
    Paulick R; Caffier H
    Med Klin (Munich); 1987 May; 82(11):385-91. PubMed ID: 3600541
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum sialyltransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors.
    Ganzinger U; Deutsch E
    Cancer Res; 1980 Apr; 40(4):1300-4. PubMed ID: 7357558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.